Clinical trial
Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma
NCT02648399 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma
- Lead sponsor
- Fujian Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid papillary carcinoma